- Condition: Methamphetamine Abuse
Interventions: Biological: normal saline; Biological: ch-mAb7f9
Sponsors: InterveXion Therapeutics, LLC; National Institute on Drug Abuse (NIDA); University of Arkansas
Recruiting - verified May 2012 - Condition: Morbid Obesity
Interventions: Drug: Ephedrine sulfate with caffeine; Drug: cellulose
Sponsors: Oregon Weight Loss Surgery, LLC; Oregon Weight Loss Surgery, LLC
Not yet recruiting - verified May 2012 - Condition: HIV Dementia
Interventions: Drug: Long acting methylphenidate; Drug: Long acting methylphenidate; Drug: Matched placebo
Sponsors: University of California, Los Angeles; University of California, Los Angeles
Recruiting - verified May 2012 - Condition: Cigarette Smoking
Interventions: Drug: Nicotine replacement therapy - transdermal nicotine patch; Behavioral: Tailored behavioral intervention; Behavioral: Tobacco quitline referral; Drug: Nicotine replacement therapy - nicotine gum; Drug: Nicotine replacement therapy - nicotine lozenge; Drug: Bupropion SR; Drug: Varenicline; Drug: Combination pharmacotherapy - transdermal nicotine patch + nicotine gum; Drug: Combination pharmacotherapy - transdermal nicotine patch + nicotine lozenge; Drug: Combination pharmacotherapy - transdermal nicotine patch + bupropion; Behavioral: Alcohol use risk reduction; Behavioral: Behavioral activation for the treatment of depression; Behavioral: Behavioral management of post-cessation weight gain
Sponsors: University of Iowa; University of Iowa; Department of Veterans Affairs
Not yet recruiting - verified May 2012 - Condition: Nicotine Dependence
Intervention: Drug: Intravenous Nicotine
Sponsors: Mclean Hospital; Mclean Hospital; National Institute on Drug Abuse (NIDA)
Recruiting - verified May 2012 - Condition: AOD Effects and Consequences
Interventions: Drug: Alprazolam; Drug: Dextroamphetamine
Sponsors: Mclean Hospital; Mclean Hospital
Not yet recruiting - verified April 2012 - Condition: Methamphetamine Dependence
Intervention: Behavioral: Text messages
Sponsors: New Leaf Treatment Center; New Leaf Treatment Center
Recruiting - verified April 2012 - Condition: Advanced Solid Tumors, Excluding Breast Cancer
Interventions: Drug: caffeine; Drug: diclofenac; Drug: omeprazole; Drug: midazolam; Drug: TKI258
Sponsors: Novartis; Novartis Pharmaceuticals
Not yet recruiting - verified May 2012 - Conditions: Cigarette Smoking; Nicotine Dependence
Interventions: Drug: varenicline (Chantix); Drug: bupropion (Zyban) & nicotine patches; Drug: nicotine patches
Sponsors: Duke University; Duke University; Philip Morris USA, Inc.
Recruiting - verified May 2012 - Condition: Methamphetamine Dependence
Interventions: Drug: Atomoxetine; Drug: placebo
Sponsors: University of Arkansas; University of Arkansas; National Institute on Drug Abuse (NIDA)
Recruiting - verified May 2012 - Condition: Nicotine Dependence
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute on Drug Abuse (NIDA)
Recruiting - verified February 2012 - Condition: Parkinson's Disease
Intervention: Drug: nicotine transdermal patch
Sponsors: University of Vermont; James BOYD MD; Michael J. Fox Foundation for Parkinson's Research
Not yet recruiting - verified March 2012 - Condition: Attention-deficit/Hyperactivity Disorder
Interventions: Drug: Lisdexamfetamine dimesylate; Drug: Methylphenidate Hydrochloride; Drug: Placebo
Sponsors: Shire Development LLC; Shire Development LLC
Recruiting - verified May 2012 - Condition: Attention-deficit/Hyperactivity Disorder
Interventions: Drug: Lisdexamfetamine dimesylate; Drug: Methylphenidate Hydrochloride; Drug: Placebo
Sponsors: Shire Development LLC; Shire Development LLC
Recruiting - verified May 2012 - Condition: Smoking Cessation
Interventions: Behavioral: WEB; Behavioral: Social Network; Behavioral: Nicotine Replacement Therapy (NRT)
Sponsors: American Legacy Foundation; American Legacy Foundation; National Cancer Institute (NCI)
Recruiting - verified March 2012 - Conditions: Methamphetamine Dependence; Methamphetamine Abuse; Substance Abuse
Interventions: Drug: Placebo; Drug: Varenicline; Drug: Varenicline
Sponsors: Baylor College of Medicine; Baylor College of Medicine; National Institute on Drug Abuse (NIDA)
Recruiting - verified April 2012 - Conditions: Attention Deficit Hyperactivity Disorder; Delayed Circadian Rhythm Disorder
Intervention: Device: Polarized glasses designed to filter out blue light
Sponsors: University of Alabama at Birmingham; University of Alabama at Birmingham
Recruiting - verified March 2012 - Conditions: Attention Deficit Hyperactivity Disorder (ADHD); Executive Function Deficits (EFD)
Interventions: Drug: Placebo; Drug: Memantine Hydrochloride; Drug: OROS-Methylphenidate
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; American Professional Society of ADHD and Related Disorders
Not yet recruiting - verified April 2012 - Condition: Methamphetamine Metabolism, CYP2D6 Genotype
Intervention: Drug: A single oral 5 mg of duterium labeled methamphetamine
Sponsors: California Pacific Medical Center Research Institute; California Pacific Medical Center Research Institute; The Children's Mercy Hospital
Not yet recruiting - verified October 2009 - Condition: Tobacco Use Disorder
Intervention: Drug: Nicotine lozenge 4 mg
Sponsors: University of Minnesota - Clinical and Translational Science Institute; University of Minnesota - Clinical and Translational Science Institute; National Institute on Drug Abuse (NIDA)
Recruiting - verified January 2012 - Conditions: Depression; Substance Abuse; Substance Use
Intervention: Drug: Creatine monohydrate
Sponsors: University of Utah; Perry Renshaw
Recruiting - verified April 2012 - Condition: Hyperopia
Intervention: Procedure: Glasses
Sponsors: Jaeb Center for Health Research; Jaeb Center for Health Research; National Eye Institute (NEI)
Recruiting - verified April 2012 - Condition: Nicotine Dependence
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute on Drug Abuse (NIDA)
Recruiting - verified November 2011 - Condition: Smoking
Interventions: Other: Very low level nicotine containing cigarette; Other: Low nicotine level cigarette; Other: Moderate level nicotine cigarette
Sponsors: Masonic Cancer Center, University of Minnesota; Masonic Cancer Center, University of Minnesota
Recruiting - verified May 2012 - Condition: Psychosocial Problem
Interventions: Behavioral: Health Education; Behavioral: Questionnaires; Behavioral: Telephone Counseling Sessions; Drug: Nicotine Patches
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center; National Institutes of Health (NIH)
Recruiting - verified January 2012 - Condition: Solid Tumors
Interventions: Drug: tivantinib; Drug: omeprazole; Drug: s-warfarin; Drug: caffeine; Dietary Supplement: vitamin K; Drug: digoxin; Drug: midazolam
Sponsors: Daiichi Sankyo Inc.; Daiichi Sankyo Inc.; Medpace, Inc.
Recruiting - verified January 2012 - Condition: Nicotine Dependence
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute on Drug Abuse (NIDA)
Recruiting - verified October 2011 - Condition: Smoking Cessation
Interventions: Behavioral: Telephone counseling; Drug: Nicotine-replacement therapy (patches); Behavioral: Monetary incentives
Sponsors: University of California, San Diego; University of California, San Diego; University of California, San Francisco; Centers for Medicare and Medicaid Services; California Department of Health Services
Not yet recruiting - verified December 2011 - Condition: Anorexia
Interventions: Drug: megestrol acetate; Drug: Arm B (megestrol plus mirtazapine)
Sponsors: Washington University School of Medicine; Washington University School of Medicine
Recruiting - verified April 2012 - Condition: Nicotine Addiction
Interventions: Drug: Saline; Drug: Nicotine
Sponsors: Yale University; Yale University
Recruiting - verified December 2011 - Condition: Cocaine Dependence
Intervention: Drug: lisdexamfetamine
Sponsors: University of Minnesota - Clinical and Translational Science Institute; University of Minnesota - Clinical and Translational Science Institute
Recruiting - verified December 2011 - Condition: Cigarette Smoking
Interventions: Behavioral: contingency management for smoking abstinence; Drug: transdermal nicotine; Behavioral: Telephone counseling
Sponsors: University of Connecticut Health Center; University of Connecticut Health Center; National Institute on Drug Abuse (NIDA)
Recruiting - verified March 2012 - Condition: Cocaine Dependence
Intervention: Drug: Lisdexamfetamine
Sponsors: New York State Psychiatric Institute; New York State Psychiatric Institute; National Institute on Drug Abuse (NIDA)
Recruiting - verified May 2012 - Conditions: Nicotine Dependence; Smoking Cessation
Interventions: Drug: EVP-6124; Drug: Placebo Capsule; Drug: NicoDerm CQ Patch (Active); Drug: NRT Patch (Placebo); Behavioral: Brief Supportive and Behavioral Treatment
Sponsors: Massachusetts General Hospital; A. Eden Evins; EnVivo Pharmaceuticals, Inc.; National Institute on Drug Abuse (NIDA)
Recruiting - verified April 2012 - Condition: Smoking Cessation
Interventions: Other: standard care; Other: standard care plus contingency management
Sponsors: Yale University; Yale University
Recruiting - verified April 2012 - Condition: Menopause
Intervention: Drug: Armodafinil
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; Cephalon
Recruiting - verified October 2011 - Condition: Smoking Cessation
Interventions: Drug: Placebo; Drug: varenicline tartrate; Drug: bupropion hydrochloride; Drug: Nicotine Replacement Therapy Patch
Sponsors: Pfizer; Pfizer; GlaxoSmithKline
Recruiting - verified May 2012 - Condition: Hepatitis C
Interventions: Drug: Armodafinil; Drug: Placebo
Sponsors: Research Foundation for Mental Hygiene; Research Foundation for Mental Hygiene; Mount Sinai School of Medicine; Weill Medical College of Cornell University
Recruiting - verified November 2011 - Condition: Smoking
Intervention: Behavioral: Behavior smoking cessation counseling with nicotine patch
Sponsors: Brown University; Brown University; National Cancer Institute (NCI)
Recruiting - verified October 2011 - Condition: Amphetamine-Related Disorders
Interventions: Drug: extended-release naltrexone; Drug: Placebo
Sponsors: National Institute on Drug Abuse (NIDA); National Institute on Drug Abuse (NIDA); Alkermes
Not yet recruiting - verified October 2011 - Condition: Major Depressive Disorder
Interventions: Drug: Amphetamine-dextroamphetamine (AMPH); Drug: Placebo; Behavioral: Well-being therapy
Sponsors: Massachusetts General Hospital; David P. Soskin,M.D.; Harvard University
Recruiting - verified March 2012 - Condition: Smoking Cessation
Interventions: Drug: Meclizine; Drug: Nicotine patches
Sponsors: Duke University; Duke University; Philip Morris USA, Inc.
Recruiting - verified March 2012 - Condition: Major Depressive Disorder
Interventions: Drug: Antidepressant + SPD489 (Lisdexamfetamine dimesylate) 10 mg; Drug: Antidepressant + SPD489 (Lisdexamfetamine dimesylate) 30 mg; Drug: Antidepressant + SPD489 (Lisdexamfetamine dimesylate) 50 mg; Drug: Antidepressant + SPD489 (Lisdexamfetamine dimesylate) 70 mg; Drug: Antidepressant + Placebo
Sponsors: Shire Development LLC; Shire Development LLC
Recruiting - verified March 2012 - Condition: Major Depressive Disorder
Interventions: Drug: Antidepressant + SPD489 (Lisdexamfetamine dimesylate ); Drug: Antidepressant + Placebo
Sponsors: Shire Development LLC; Shire Development LLC
Recruiting - verified March 2012 - Condition: Major Depressive Disorder
Interventions: Drug: SPD489 (Lisdexamfetamine dimesylate ); Drug: Placebo
Sponsors: Shire Development LLC; Shire Development LLC
Recruiting - verified May 2012 - Condition: Cigarette Smoking
Interventions: Drug: Transdermal Nicotine Patch; Drug: Transdermal Placebo Patch
Sponsors: Brentwood Biomedical Research Institute; Brentwood Biomedical Research Institute
Not yet recruiting - verified February 2012 - Condition: Fatigue
Intervention: Dietary Supplement: DGB-01 Supplementation
Sponsors: University of Kentucky; Michael Reid, Ph.D; Immunotec Inc.
Recruiting - verified March 2012 - Conditions: Major Depressive Disorder; Bipolar Disorder
Interventions: Behavioral: Wake Therapy; Device: lightbox; Drug: Lithium Carbonate; Drug: Armodafinil
Sponsors: New York State Psychiatric Institute; New York State Psychiatric Institute
Recruiting - verified April 2012 - Conditions: Posttraumatic Stress Disorder; Traumatic Brain Injury
Interventions: Drug: Methylphenidate Hydrochloride 20 mg; Drug: Placebo Capsule; Drug: Galantamine 12 mg
Sponsors: INTRuST, Post-Traumatic Stress Disorder - Traumatic Brain Injury Clinical Consortium; INTRuST, Post-Traumatic Stress Disorder - Traumatic Brain Injury Clinical Consortium; U.S. Army Medical Research and Materiel Command
Recruiting - verified January 2012 - Condition: Nicotine Dependence
Intervention:
Sponsors: Medical University of South Carolina; Medical University of South Carolina
Recruiting - verified July 2011 - Condition: Prostate Cancer
Interventions: Other: Placebo; Drug: Methylphenidate; Behavioral: Counseling Sessions; Other: Sham Exercise; Other: Standardized Exercise Intervention Program; Other: Cognitive Behavioral Therapy (CBT)
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center; American Cancer Society
Recruiting - verified April 2012 - Condition: Attention Deficit Hyperactivity Disorder
Interventions: Drug: Lisdexamfetamine; Drug: Placebo
Sponsors: Columbia University; Columbia University; Shire Development LLC
Not yet recruiting - verified August 2011 - Conditions: Obesity; Phentermine Withdrawal
Intervention: Drug: Abrupt cessation of phentermine pharmacotherapy
Sponsors: Center for Weight Management, California; Center for Weight Management, California; American Society of Bariatric Physicians
Recruiting - verified August 2011 - Condition: Malignant Glioma
Interventions: Drug: Nuvigil®; Drug: Placebo
Sponsors: H. Lee Moffitt Cancer Center and Research Institute; H. Lee Moffitt Cancer Center and Research Institute; Cephalon
Recruiting - verified May 2012 - Conditions: Attention Deficit Hyperactivity Disorder (ADHD); Deficient Emotional Self-Regulation (DESR)
Interventions: Drug: OROS-Methylphenidate; Drug: Omega-3 Fatty Acids
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital
Recruiting - verified February 2012 - Conditions: Heroin Dependence; Nicotine Dependence
Interventions: Drug: Pioglitazone; Drug: Placebo
Sponsors: New York State Psychiatric Institute; New York State Psychiatric Institute; National Institute on Drug Abuse (NIDA); Omeros Corporation
Recruiting - verified July 2011 - Conditions: Brain and Central Nervous System Tumors; Cognitive/Functional Effects; Fatigue; Neurotoxicity; Psychosocial Effects of Cancer and Its Treatment
Interventions: Drug: modafinil; Other: placebo
Sponsors: National Cancer Institute (NCI); University of South Florida; National Cancer Institute (NCI)
Recruiting - verified September 2011 - Condition: Nicotine Dependence
Interventions: Drug: Varenicline; Drug: Bupropion; Drug: Nicotine patches
Sponsors: Duke University; Duke University; National Institute on Drug Abuse (NIDA)
Recruiting - verified January 2012 - Conditions: Cigarette Smoking; Drug Use
Interventions: Behavioral: Standard Treatment; Behavioral: BAD-AS; Drug: Transdermal Nicotine Patch
Sponsors: University of Maryland; University of Maryland; American Cancer Society
Recruiting - verified July 2011 - Condition: Methamphetamine Dependence
Intervention: Drug: Doxazosin extended release
Sponsors: University of Arkansas; University of Arkansas; National Institute on Drug Abuse (NIDA); Baylor College of Medicine
Recruiting - verified November 2011 - Condition: Nicotine Dependence
Interventions: Behavioral: Standard treatment; Behavioral: Standard treatment+practice quitting
Sponsors: Rutgers University; Rutgers University; National Institute on Drug Abuse (NIDA)
Recruiting - verified June 2011 - Conditions: Methamphetamine Dependence; Substance Abuse; Methamphetamine Abuse
Interventions: Drug: Varenicline; Drug: Placebo
Sponsors: University of California, Los Angeles; University of California, Los Angeles
Recruiting - verified March 2012 - Condition: Cigarette Smoking Behavior
Intervention: Drug: Nicotine polacrilex
Sponsors: University of California, Los Angeles; University of California, Los Angeles; Philip Morris Products S.A.
Not yet recruiting - verified June 2011 - Condition: Methamphetamine Dependence
Interventions: Other: placebo; Drug: Naltrexone and Bupropion SR
Sponsors: National Institute on Drug Abuse (NIDA); National Institute on Drug Abuse (NIDA)
Recruiting - verified August 2011 - Condition: Methamphetamine Dependence
Intervention: Drug: Modafinil
Sponsors: California Pacific Medical Center Research Institute; California Pacific Medical Center Research Institute
Recruiting - verified January 2012 - Condition: Smoking
Intervention: Drug: Transdermal Nicotine Patch
Sponsors: University of Maryland; University of Maryland; National Institutes of Health (NIH); National Institute on Drug Abuse (NIDA)
Recruiting - verified June 2011 - Conditions: Obstructive Sleep Apnea; Enlargement of Tonsil or Adenoid
Interventions: Drug: Caffeine and sodium Benzoate 10 mg/kg IV; Drug: Caffeine and Sodium Benzoate 20 mg/kg IV; Drug: 0.9 NS Saline
Sponsors: The University of Texas Health Science Center, Houston; The University of Texas Health Science Center, Houston; Memorial Hermann Hospital
Recruiting - verified March 2012 - Condition: Smokeless Tobacco Cessation
Interventions: Drug: Commit® nicotine lozenges (4 mg).; Behavioral: Phone Counseling; Behavioral: Self-help materials
Sponsors: Oregon Research Institute; Oregon Research Institute; National Cancer Institute (NCI); Mayo Clinic
Recruiting - verified January 2012 - Conditions: Head And Neck Cancer; Fatigue
Interventions: Drug: Armodafinil; Other: Placebo; Behavioral: Questionnaires
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center; National Cancer Institute (NCI)
Recruiting - verified January 2012 - Conditions: Symptomatic Menopause; Cognitive Impairments
Intervention: Drug: Lisdexamfetamine
Sponsors: University of Pennsylvania; University of Pennsylvania; Shire Development LLC
Recruiting - verified April 2012 - Condition: Marijuana Dependence
Interventions: Drug: Nicotine; Drug: Placebo Patch
Sponsors: Southern Illinois University Carbondale; Southern Illinois University Carbondale; National Institute on Drug Abuse (NIDA)
Recruiting - verified March 2012 - Condition: Lung Cancer
Interventions: Drug: Armodafinil; Other: Placebo; Drug: Minocycline; Behavioral: Questionnaires
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center; National Cancer Institute (NCI)
Recruiting - verified March 2012 - Condition: Nicotine Addiction
Interventions: Drug: Varenicline; Drug: Placebo; Drug: Transdermal Nicotine
Sponsors: University of Pennsylvania; University of Pennsylvania; National Institute on Drug Abuse (NIDA)
Recruiting - verified January 2012 - Condition: Depression
Interventions: Drug: Armodafinil; Drug: Placebo
Sponsors: Teva Pharmaceutical Industries; Cephalon
Recruiting - verified May 2012 - Condition: Nicotine Dependence
Interventions: Drug: Varenicline; Drug: Bupropion; Drug: Nicotine patches; Drug: Nicotine Inhaler
Sponsors: Duke University; Duke University; National Institute on Drug Abuse (NIDA); Philip Morris USA, Inc.
Recruiting - verified March 2012 - Condition: Smoking Cessation
Interventions: Behavioral: Questionnaires; Drug: Nicotine Patch Therapy; Behavioral: Counseling Sessions
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center; CPRIT - Cancer Prevention Research Institute of Texas
Not yet recruiting - verified November 2011 - Condition: Smoking Cessation
Interventions: Drug: Nicotine Patches; Behavioral: Telephone Counseling; Behavioral: Brief Hospital Counseling
Sponsors: University of California, San Diego; University of California, San Diego; National Cancer Institute (NCI)
Recruiting - verified January 2011 - Condition: Alcohol or Other Drugs Effects
Interventions: Drug: Alcohol + Caffeine Beverage; Drug: Alcohol + Caffeine-placebo
Sponsors: Johns Hopkins University; Johns Hopkins University; National Institute on Drug Abuse (NIDA)
Recruiting - verified January 2011 - Conditions: Smoking; Smoking Cessation
Interventions: Other: Coordinated Care; Other: Usual Care
Sponsors: University of Pittsburgh; University of Pittsburgh; National Institutes of Health (NIH); National Cancer Institute (NCI)
Recruiting - verified September 2011 - Condition: Attention Deficit/Hyperactivity Disorder
Interventions: Drug: Placebo; Drug: RIT124D; Drug: RIT124D; Drug: RIT124D
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified April 2012 - Conditions: Crystal Methamphetamine Abuse; Crystal Methamphetamine Dependence
Interventions: Behavioral: Behavioral Activation Therapy and Risk Reduction Counseling (BAT-RR); Behavioral: Information, Motivation, Behavioral skills change approach to sexual risk reduction
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; Fenway Community Health
Recruiting - verified May 2012 - Condition: Cholangiocarcinoma
Intervention: Device: TheraSphere® Yttrium-90 (Y-90) Microspheres
Sponsors: H. Lee Moffitt Cancer Center and Research Institute; H. Lee Moffitt Cancer Center and Research Institute; Nordion (Canada) Inc.
Recruiting - verified January 2012 - Conditions: Tobacco Use Disorder; Smoking Relapse; Cognitive Training; Nicotine Addiction
Interventions: Behavioral: Cognitive Remediation Training (CRT); Behavioral: Standard Care (SC)
Sponsors: University of Pennsylvania; University of Pennsylvania
Recruiting - verified January 2012 - Conditions: Smoking Cessation; Overweight; Obesity
Intervention: Drug: Nicotine patch
Sponsors: Yale University; Yale University; American Heart Association
Recruiting - verified February 2012 - Condition: Attention-Deficit/Hyperactivity Disorder
Interventions: Drug: Lovaza; Dietary Supplement: Placebo (corn oil).
Sponsors: Maimonides Medical Center; Maimonides Medical Center; GlaxoSmithKline
Recruiting - verified August 2011 - Conditions: HIV; AIDS; Substance Use Disorders
Intervention: Behavioral: Resilient Affective Processing Therapy (RAPT)
Sponsors: University of California, San Francisco; University of California, San Francisco
Recruiting - verified March 2012 - Condition: Nicotine
Intervention:
Sponsors: University of Pennsylvania; University of Pennsylvania; National Institute on Drug Abuse (NIDA)
Recruiting - verified December 2011 - Conditions: Substance-Related Disorders; Dental Caries
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Dental and Craniofacial Research (NIDCR)
Recruiting - verified September 2010 - Condition: Tobacco Use Disorder
Interventions: Behavioral: Cue Extinction Training; Drug: Nicotine Replacement Therapy; Behavioral: Cue Extinction Therapy; Behavioral: Progressive Muscle Relaxation
Sponsors: New York State Psychiatric Institute; New York State Psychiatric Institute
Recruiting - verified April 2012 - Condition: Head And Neck Cancer
Interventions: Other: Placebo; Drug: Curcumin; Drug: Armodafinil; Drug: Minocycline; Drug: Bupropion
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center; National Cancer Institute (NCI)
Not yet recruiting - verified May 2012 - Conditions: Methamphetamine-dependence; Substance Abuse
Interventions: Drug: Ibudilast; Drug: Ibudilast; Drug: Ibudilast
Sponsors: University of California, Los Angeles; University of California, Los Angeles; National Institute on Drug Abuse (NIDA); MediciNova
Recruiting - verified March 2012 - Condition: Parkinson's Disease
Interventions: Drug: nicotine patch; Drug: placebo
Sponsors: University of Vermont; University of Vermont; Parkinson's Disease Foundation; The Parkinson Study Group
Recruiting - verified October 2010 - Condition: Chronic Oral Food Refusal
Interventions: Drug: Amitriptyline 1 mg/kg; Drug: Placebo
Sponsors: University of Kansas; Ann Davis, PhD, MPH, ABPP
Recruiting - verified March 2012 - Condition: for Cigarette Smoking and Binge Drinking Cessation
Interventions: Drug: nicotine transdermal patch; Behavioral: behavioral intervention
Sponsors: Mayo Clinic; Mayo Clinic; James and Esther King Biomedical Research Program
Recruiting - verified April 2012 - Condition: Non-treatment Seeking Methamphetamine Users
Interventions: Drug: oral placebo and methamphetamine 20mg po; Drug: Prazosin 1mg po and oral methamphetamine placebo; Drug: Prazosin 1mg po and Methamphetamine 20mg po
Sponsors: University of Arkansas; University of Arkansas; National Institute on Drug Abuse (NIDA)
Recruiting - verified February 2012 - Conditions: Cocaine Dependence; Cocaine Withdrawal
Interventions: Drug: controlled release carvedilol; Drug: Placebo
Sponsors: University of Arkansas; University of Arkansas; National Institute on Drug Abuse (NIDA); Baylor College of Medicine
Recruiting - verified May 2012 - Condition: Chronic Myeloid Leukemia
Interventions: Drug: Placebo; Drug: Armodafinil
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center
Recruiting - verified April 2012 - Conditions: Fatigue; Multiple Myeloma
Interventions: Drug: armodafinil; Drug: Placebo
Sponsors: Oncotherapeutics; Oncotherapeutics; Cephalon
Recruiting - verified February 2012 - Conditions: HIV+; Fatigue; Unmet Vocational Goals
Interventions: Behavioral: Behavioral Activation Therapy-; Behavioral: Supportive Counseling
Sponsors: Research Foundation for Mental Hygiene; Research Foundation for Mental Hygiene
Recruiting - verified November 2011 - Condition: Major Depressive Disorder
Intervention: Drug: Lisdexamfetamine Dimesylate 20-50 mg
Sponsors: Mclean Hospital; Mclean Hospital; Shire Development LLC
Recruiting - verified March 2012 - Conditions: Stimulant-Related Disorders; HIV; HIV Infections
Intervention: Drug: Truvada
Sponsors: Friends Research Institute, Inc.; Friends Research Institute, Inc.; University of California, Los Angeles
Recruiting - verified October 2011 - Conditions: Drug Addiction; Nicotine Dependence
Intervention: Drug: Nicotrol
Sponsors: National Institutes of Health Clinical Center (CC); National Institute on Drug Abuse (NIDA)
Recruiting - verified September 2011 - Conditions: Attention Deficit Hyperactivity Disorder; Reading Difficulty or Disability
Interventions: Drug: Methylphenidate; Behavioral: Intensive reading instruction; Behavioral: Parent Training; Drug: Mixed Salt Amphetamine; Drug: Atomoxetine; Drug: Guanfacine
Sponsors: The University of Texas Health Science Center, Houston; The University of Texas Health Science Center, Houston; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified February 2012 - Condition: Dental Caries
Interventions: Device: Fluoride Varnish; Device: Glass Ionomer Sealant
Sponsors: University of California, San Francisco; University of California, San Francisco; National Institute of Dental and Craniofacial Research (NIDCR)
Recruiting - verified March 2012 - Condition: ADHD
Intervention: Drug: lisdexamfetamine
Sponsors: Florida International University; Florida International University
Recruiting - verified April 2012 - Condition: Tobacco Use Cessation
Interventions: Other: proactive outreach (PRO); Other: Free telephone counseling (TC); Other: Nicotine replacement therapy (NRT); Other: Usual care (UC)
Sponsors: Masonic Cancer Center, University of Minnesota; Masonic Cancer Center, University of Minnesota; National Cancer Institute (NCI)
Recruiting - verified September 2011 - Conditions: HIV Medication Adherence; Methamphetamine Use; Sexual Risk; Poly-substance Use; HIV Infections
Interventions: Behavioral: Motivational Interviewing + Cognitive Behavioral Skills Training; Behavioral: Education Attention Control
Sponsors: Hunter College; Hunter College
Recruiting - verified June 2011 - Conditions: Smoking; Smoking Cessation; Motivation; Nicotine
Interventions: Drug: Nicotine Patch; Drug: Nicotine Gum; Behavioral: Motivational Interviewing; Behavioral: Smoking Reduction
Sponsors: University of Wisconsin, Madison; University of Wisconsin, Madison; University of Illinois; Dean Health System; Mercy Health System; Aurora Health Care; National Cancer Institute (NCI)
Recruiting - verified August 2011 - Conditions: Substance Abuse; HIV Infections
Intervention: Behavioral: Stonewall Project
Sponsors: University of California, San Francisco; University of California, San Francisco; California HIV/AIDS Research Program
Recruiting - verified March 2012 - Condition: Depression
Intervention: Drug: Armodafinil
Sponsors: Teva Pharmaceutical Industries; Cephalon
Recruiting - verified May 2012 - Conditions: Smoking; Smoking Cessation; Adherence; Nicotine; Motivation
Interventions: Drug: Short Term Combination Nicotine Replacement Therapy (patch + gum); Drug: Long Term Combination Nicotine Replacement Therapy (patch + gum); Behavioral: Intensive Maintenance Counseling; Behavioral: Cognitive Medication Adherence Counseling (C-MAC); Behavioral: Electronic Medication Monitoring Device (the Helping Hand) + Feedback; Behavioral: Automated Adherence Prompting Phone Calls
Sponsors: University of Wisconsin, Madison; University of Wisconsin, Madison; Dean Health System; Mercy Health System; Aurora Health Care; National Cancer Institute (NCI)
Recruiting - verified August 2011 - Conditions: ADHD; Growth
Interventions: Behavioral: behavioral therapy; Drug: 12 hour methylphenidate product; Behavioral: increased monitoring of growth; Drug: drug holiday; Dietary Supplement: caloric supplement
Sponsors: Florida International University; Florida International University
Recruiting - verified March 2012 - Conditions: Smoking; Smoking Cessation; Nicotine
Interventions: Behavioral: Counseling before quit attempt; Behavioral: Minimal In-person counseling during quit attempt; Behavioral: Intensive in-person counseling; Behavioral: Minimal phone counseling after quit date; Behavioral: Intensive phone counseling; Drug: Short Term Nicotine Patch During Quit Attempt; Drug: Long Term Nicotine Patch During Quit Attempt; Drug: Short Term Post-Quit Nicotine Gum; Drug: Long Term Nicotine Gum During Quit Attempt; Drug: Pre-Quit Nicotine Gum; Drug: Pre-Quit Nicotine Patch
Sponsors: University of Wisconsin, Madison; University of Wisconsin, Madison; Dean Health System; Mercy Health System; Aurora Health Care; National Cancer Institute (NCI)
Recruiting - verified August 2011 - Condition: Attention-Deficit/Hyperactivity Disorder
Interventions: Drug: Lisdexamfetamine Dimesylate; Drug: Atomoxetine Hydrochloride
Sponsors: Shire Development LLC; Shire Development LLC
Recruiting - verified March 2012 - Condition: Bipolar Depression
Interventions: Drug: Lisdexamfetamine; Drug: Placebo
Sponsors: Lindner Center of HOPE; Lindner Center of HOPE; Shire Development LLC; University of Cincinnati
Recruiting - verified April 2012 - Condition: Tobacco Dependence
Intervention: Drug: nicotine patch
Sponsors: University of Massachusetts, Worcester; University of Massachusetts, Worcester
Recruiting - verified April 2012 - Condition: Binge Eating Disorder
Interventions: Drug: lisdexamfetamine; Drug: Placebo control
Sponsors: Lindner Center of HOPE; Lindner Center of HOPE; Shire Development LLC; University of Cincinnati
Recruiting - verified April 2012 - Conditions: Bipolar; Depression
Interventions: Drug: Lisdexamfetamine; Drug: Placebo control
Sponsors: Lindner Center of HOPE; Lindner Center of HOPE; Shire Development LLC; University of Cincinnati
Recruiting - verified April 2012 - Conditions: Neglect; Dysphagia
Interventions: Drug: Modafinil; Drug: Placebo
Sponsors: University of Arkansas; University of Arkansas; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified April 2012 - Condition: Depression
Interventions: Drug: Armodafinil; Drug: Armodafinil; Drug: Placebo
Sponsors: Teva Pharmaceutical Industries; Cephalon
Recruiting - verified May 2012 - Condition: Smoking
Interventions: Behavioral: Cognitive Behavioral Treatment; Drug: Nicotine Patch; Behavioral: Wellness Program; Behavioral: Aerobic Exercise
Sponsors: Southern Methodist University; Southern Methodist University; National Institute on Drug Abuse (NIDA)
Recruiting - verified July 2011 - Conditions: Methamphetamine Dependence; Methamphetamine Abuse; Substance Abuse
Interventions: Drug: Perindopril; Drug: Placebo; Drug: Candesartan
Sponsors: Baylor College of Medicine; Baylor College of Medicine; National Institute on Drug Abuse (NIDA)
Recruiting - verified February 2012 - Condition: Attention Deficit Hyperactivity Disorder
Intervention: Drug: Osmotic Release Methylphenidate
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; ElMindA Ltd
Recruiting - verified October 2011 - Condition: Cigarette Smoking
Intervention: Drug: Deuterated nicotine and cotinine
Sponsors: University of California, San Francisco; University of California, San Francisco
Recruiting - verified March 2012 - Condition: Nicotine Dependence
Interventions: Drug: Bupropion SR; Drug: Nicotine; Drug: Placebo pill and Placebo Patch; Other: Delayed-Quit Control
Sponsors: Southern Illinois University Carbondale; Southern Illinois University Carbondale; National Institute on Drug Abuse (NIDA)
Recruiting - verified September 2011 - Condition: Nicotine Dependence
Intervention: Drug: Transdermal nicotine patch
Sponsors: University of Pennsylvania; University of Pennsylvania; National Institute on Drug Abuse (NIDA)
Recruiting - verified December 2011 - Conditions: Nicotine Dependence; Smoking; Sleep Disorders, Intrinsic
Intervention: Behavioral: Exercise
Sponsors: University of Pittsburgh; University of Pittsburgh; National Institute on Drug Abuse (NIDA)
Recruiting - verified May 2012 - Condition: Methamphetamine Dependence
Interventions: Drug: methylphenidate; Drug: Methylphenidate
Sponsors: University of California, Los Angeles; University of California, Los Angeles
Recruiting - verified January 2010 - Conditions: Nicotine Dependence; Schizophrenia
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute on Drug Abuse (NIDA)
Recruiting - verified August 2011 - Condition: Nicotine Dependence
Intervention: Device: Transcranial Magnetic Stimulation
Sponsors: National Institutes of Health Clinical Center (CC); National Institute on Drug Abuse (NIDA); University of Maryland
Recruiting - verified December 2011 - Condition: Nicotine Dependence
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute on Drug Abuse (NIDA)
Recruiting - verified January 2011 - Conditions: Attention Deficit Hyperactivity Disorder; Glucose Intolerance; Obesity
Intervention: Drug: Lis-dexamphetamine
Sponsors: Duke University; Duke University; Shire Development LLC
Recruiting - verified March 2012 - Conditions: Binge Eating Disorder; Overweight; Obese
Interventions: Drug: Armodafinil; Drug: Armodafinil; Drug: Matching placebo
Sponsors: Lindner Center of HOPE; Lindner Center of HOPE; Cephalon; University of Cincinnati
Recruiting - verified April 2012 - Conditions: Smoking Cessation; Schizophrenia
Intervention: Drug: Nicotine Nasal Spray
Sponsors: University of Medicine and Dentistry New Jersey; University of Medicine and Dentistry New Jersey; National Institute on Drug Abuse (NIDA)
Recruiting - verified August 2011 - Condition: Tobacco Use Disorder
Interventions: Drug: Tolcapone; Drug: Placebo
Sponsors: University of Pennsylvania; University of Pennsylvania; National Institute on Drug Abuse (NIDA)
Recruiting - verified January 2012 - Conditions: Smoking Cessation; Smoking
Interventions: Behavioral: Standard Treatment (ST); Behavioral: Telephone Counseling; Behavioral: Quitline; Behavioral: Nicotine Replacement Therapy (NRT)
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center; National Cancer Institute (NCI)
Recruiting - verified December 2011 - Condition: Influence of OPRM1 A118G Status on Subjective Responses to IV Nicotine.
Intervention: Drug: Nicotine
Sponsors: Yale University; Yale University; National Institute on Drug Abuse (NIDA)
Recruiting - verified December 2011 - Condition: Methamphetamine Dependence
Interventions: Drug: Citicoline; Drug: Placebo
Sponsors: University of Utah; Perry Renshaw; National Institute on Drug Abuse (NIDA)
Recruiting - verified April 2012 - Condition: Advanced Malignancies
Intervention: Biological: CDX-1401 in combination with Resiquimod and/or Poly-ICLC
Sponsors: Celldex Therapeutics; Celldex Therapeutics
Recruiting - verified November 2011 - Condition: Smokeless Tobacco Use
Interventions: Drug: nicotine replacement therapy (nicotine patches); Drug: placebo NRT
Sponsors: Mayo Clinic; Mayo Clinic
Recruiting - verified January 2012 - Condition: Attention Deficit/Hyperactivity Disorder
Interventions: Drug: Short Acting Methylphenidate; Drug: Long Acting Methylphenidate
Sponsors: BRC Operations Pty. Ltd.; BRC Operations Pty. Ltd.
Recruiting - verified January 2012 - Conditions: Apnea of Prematurity; Intraventricular Hemorrhage; White Matter Injury
Intervention: Drug: Caffeine citrate
Sponsors: Washington University School of Medicine; Washington University School of Medicine
Recruiting - verified August 2011 - Condition: Substance Abuse
Interventions: Drug: Nicotine Replacement Treatment (NRT); Behavioral: Brief Advice
Sponsors: Brown University; Brown University; National Institute on Drug Abuse (NIDA)
Recruiting - verified February 2009 - Conditions: Mood Disorder; Mental Disorder Diagnosed in Childhood; Attention Deficit and Disruptive Behavior Disorder; Attention Deficit Hyperactivity Disorder
Interventions: Drug: Citalopram; Drug: Methylphenidate
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Mental Health (NIMH)
Recruiting - verified July 2011 - Condition: Postoperative Pain
Intervention: Drug: transdermal nicotine patch
Sponsors: Stony Brook University; Stony Brook University
Recruiting - verified August 2011 - Conditions: Bladder Cancer; Cervical Cancer; Esophageal Cancer; Gastric Cancer; Head and Neck Cancer; Kidney Cancer; Leukemia; Liver Cancer; Lung Cancer; Pancreatic Cancer; Tobacco Use Disorder
Interventions: Drug: nicotine; Drug: varenicline; Other: placebo
Sponsors: Butler Hospital; Butler Hospital; National Cancer Institute (NCI)
Recruiting - verified March 2012 - Condition: Malignant Glioma
Interventions: Drug: Armodafinil; Other: Placebo
Sponsors: Dana-Farber Cancer Institute; Eudocia Quant Lee, MD; Dartmouth-Hitchcock Medical Center; University of California, San Diego; Beth Israel Deaconess Medical Center; Cephalon
Recruiting - verified December 2011 - Conditions: Smoking Cessation; Nicotine Dependence
Interventions: Drug: Nicotine Replacement Treatment (NRT); Drug: varenicline; Behavioral: Behavioral counseling for smoking cessation; Drug: Placebo patch; Drug: Placebo
Sponsors: Brown University; Brown University; National Institute on Drug Abuse (NIDA)
Recruiting - verified February 2009 - Conditions: Attention Deficit Hyperactivity Disorder; Nicotine Dependence
Interventions: Drug: Lis-dexamphetamine (LDX; Vyvanse) and Transdermal Nicotine Patch; Drug: Placebo and transdermal nicotine patch
Sponsors: Duke University; Duke University; Shire Development LLC
Recruiting - verified June 2011 - Condition: Stroke
Interventions: Drug: Sinemet, ritalin, amphetamine, and placebo; Device: Transcranial magnetic stimulation (TMS); Other: Combined drug treatment and TMS
Sponsors: Emory University; Emory University; National Institutes of Health (NIH); National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified April 2012 - Condition: Schizophrenia
Intervention: Drug: modafinil (M1, M2, M4)
Sponsors: University of California, Davis; University of California, Davis
Recruiting - verified August 2011 - Conditions: Smoking; HIV Infections
Interventions: Drug: Varenicline tartrate; Drug: Nicotine Replacement Therapy; Other: Biological Control; Behavioral: Motivational Interview
Sponsors: Ohio State University; Ohio State University; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified August 2011 - Conditions: Heroin Dependence; Opioid-Related Disorders; Cocaine Abuse or Dependence
Intervention:
Sponsors: Wayne State University; Wayne State University; National Institute on Drug Abuse (NIDA)
Recruiting - verified October 2011 - Condition: Cocaine Dependence
Interventions: Drug: Ondansetron; Drug: Placebo
Sponsors: University of Virginia; University of Virginia; National Institute on Drug Abuse (NIDA)
Recruiting - verified February 2012 - Condition: Eating Disorders
Interventions: Radiation: Positron Emission Tomography (PET) using [11C]raclopride; Drug: Methylphenidate; Procedure: Magnetic Resonance Imaging (MRI) scan
Sponsors: National Institute of Mental Health (NIMH); National Institute of Mental Health (NIMH)
Recruiting - verified November 2011 - Condition: Nicotine Dependence
Interventions: Drug: varenicline; Device: transdermal nicotine patch
Sponsors: Medical University of South Carolina; Medical University of South Carolina
Recruiting - verified July 2010 - Condition: Smoking
Intervention: Other: Functional Magnetic Resonance Imaging (fMRI)
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center; National Institutes of Health (NIH)
Recruiting - verified December 2011 - Conditions: Smoking; Smoking Cessation
Interventions: Drug: Nicotine Patch; Behavioral: Tobacco Quit Line Program
Sponsors: University of Tennessee; University of Tennessee; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified October 2011 - Conditions: Stress Disorders, Posttraumatic; Tobacco Use Disorder
Interventions: Drug: Nicotine; Behavioral: Cognitive Behavioral Therapy for Smoking Cessation; Drug: Bupropion SR
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified March 2012 - Condition: Substance-related Discorder
Interventions: Drug: Nicotine; Drug: Carfentanil
Sponsors: National Institutes of Health Clinical Center (CC); National Institute on Drug Abuse (NIDA); Johns Hopkins University
Recruiting - verified June 2011 - Condition: Liver Cancer
Interventions: Radiation: brachytherapy; Radiation: yttrium Y 90 glass microspheres
Sponsors: City of Hope Medical Center; City of Hope Medical Center; National Cancer Institute (NCI)
Recruiting - verified May 2012 - Conditions: Adult Attention Deficit Hyperactivity Disorder; Cocaine Dependence
Interventions: Drug: Placebo; Drug: Adderall-XR; Drug: Adderall-XR
Sponsors: New York State Psychiatric Institute; New York State Psychiatric Institute; National Institute on Drug Abuse (NIDA)
Recruiting - verified April 2012 - Conditions: Smoking Cessation; Tobacco Use Disorder
Interventions: Drug: Nicotine patches; Behavioral: Telephone counseling; Behavioral: iQuit Smoking website
Sponsors: University of Michigan; University of Michigan; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified January 2012 - Conditions: Smoking; Depression
Interventions: Behavioral: Smoking Cessation Treatment; Behavioral: Nicotine Replacement Therapy; Behavioral: CBASP
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center; National Institute of Mental Health (NIMH)
Recruiting - verified May 2012 - Conditions: Atypical Endometrial Hyperplasia; Endometrial Carcinoma
Intervention: Drug: Megestrol Acetate
Sponsors: New York University School of Medicine; New York University School of Medicine
Recruiting - verified March 2012 - Conditions: Preeclampsia; Hypotension
Interventions: Drug: Ephedrine; Drug: Phenylephrine
Sponsors: Northwestern University; Northwestern University
Recruiting - verified January 2012 - Condition: Brain Injury
Interventions: Drug: Methylphenidate; Behavioral: Memory and Attention Training; Other: Placebo as both treatments
Sponsors: Dartmouth-Hitchcock Medical Center; Dartmouth-Hitchcock Medical Center; National Institutes of Health (NIH)
Recruiting - verified October 2011 - Conditions: Schizophrenia; Schizoaffective Disorder
Intervention: Drug: modafinil
Sponsors: University of California, Davis; University of California, Davis
Recruiting - verified August 2011 - Condition: Cocaine Dependence
Interventions: Drug: Modafinil; Drug: placebo; Behavioral: Cognitive Behavioral Therapy (CBT)
Sponsors: University of Pennsylvania; University of Pennsylvania
Recruiting - verified November 2011 - Conditions: Smoking; Tobacco Use Cessation
Interventions: Behavioral: MBAT Group Therapy; Drug: Nicotine; Behavioral: Group Therapy; Behavioral: Individual Therapy
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center; National Institute on Drug Abuse (NIDA)
Recruiting - verified May 2012 - Conditions: Tachycardia; Chronic Orthostatic Intolerance
Interventions: Drug: Acetazolamide; Drug: Atomoxetine; Other: Baseline (No Drug); Drug: Clonidine; Drug: Entacapone; Drug: Entacapone & Propranolol; Drug: Atomoxetine & Propranolol; Drug: Indomethacin; Drug: Mecamylamine; Drug: Isosorbide Dinitrate; Dietary Supplement: Melatonin; Drug: Midodrine; Drug: Modafinil; Drug: Octreotide; Radiation: Placebo; Drug: Propranolol; Drug: Modafinil & Propranolol; Drug: Sertraline; Procedure: IV Saline; Other: Drinking Water; Device: Breathing Device; Drug: memantine; Device: Abdominal binder
Sponsors: Vanderbilt University; Satish R. Raj; National Institutes of Health (NIH)
Recruiting - verified February 2012 - Conditions: Autonomic Failure; Orthostatic Hypotension
Interventions: Drug: Atomoxetine; Drug: Acarbose; Drug: Pyridostigmine Bromide; Drug: Yohimbine; Drug: Midodrine HCl; Drug: placebo; Drug: Modafinil; Drug: Octreotide; Other: water intake; Drug: Diphenhydramine Hydrochloride; Drug: Ranitidine HCL; Drug: Tranylcypromine; Drug: Ergotamine/ Caffeine; Drug: Celecoxib; Drug: Pseudoephedrine; Drug: Methylphenidate; Drug: Indomethacin; Drug: Ibuprofen; Drug: Oxymetazoline 0.05% nasal solution; Dietary Supplement: Bovril; Drug: Acetazolamide; Drug: Rivastigmine tartrate; Drug: Carbidopa/levodopa; Device: abdominal binder; Device: abdominal binder (sham)
Sponsors: Vanderbilt University; Vanderbilt University
Recruiting - verified May 2012 - Conditions: OBESITY; HYPERTENSION; PURE AUTONOMIC FAILURE; SHY-DRAGER SYNDROME
Interventions: Drug: Trimethaphan; Drug: Trimethaphan; Drug: Pseudoephedrine
Sponsors: Vanderbilt University; Vanderbilt University
Recruiting - verified May 2012 - Conditions: Schizophrenia; Schizoaffective Disorder
Interventions: Drug: Modafinil; Procedure: Functional MRI; Procedure: Neuropsychological Testing
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Mental Health (NIMH)
Recruiting - verified June 2011
 |
Central Nervous System Stimulants Clinical Trials |
